about
Modified Lipids and Lipoproteins in Chronic Kidney Disease: A New Class of Uremic ToxinsOmega-3 polyunsaturated fatty acids and oxygenated metabolism in atherothrombosis.Glycoxidized HDL, HDL enriched with oxidized phospholipids and HDL from diabetic patients inhibit platelet function.Docosahexaenoic acid, protectin synthesis: relevance against atherothrombogenesis.In vitro and in vivo bimodal effects of docosahexaenoic acid supplements on redox status and platelet function.Alterations of endogenous sphingolipid metabolism in cardiometabolic diseases: Towards novel therapeutic approachesProteomic Characterization of High-Density Lipoprotein Particles from Non-Diabetic Hemodialysis PatientsLarge triglyceride-rich lipoproteins from fasting patients with type 2 diabetes activate platelets
P50
Q28074264-5A4D573E-FE0E-4954-90CE-FA3649B6E3E1Q34440784-F0E5CAEF-5F62-4F36-AFB0-57B9A9267B85Q36718110-0B9E51A1-500C-4881-9336-D5BAE2E4AEFFQ38156593-930FFE09-934E-4AD7-999F-4A3A7C7A7F82Q38827879-B057DFBB-E4C5-4591-832F-F20A2C089E01Q90718549-AE18F29B-A1C8-4B72-B031-B8080B417934Q91299807-A13BE8F0-0499-4BF7-A739-666834EB9994Q93076048-244469BC-F07E-4959-9B58-D89AB2BC183B
P50
description
researcher (ORCID 0000-0001-8858-6752)
@en
wetenschapper
@nl
name
Catherine Calzada
@en
Catherine Calzada
@nl
type
label
Catherine Calzada
@en
Catherine Calzada
@nl
prefLabel
Catherine Calzada
@en
Catherine Calzada
@nl
P31
P496
0000-0001-8858-6752